Bionano Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0A4K?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,8290.166%
Institutions81,5214.8%
VC/PE Firms178,33410.5%
General Public1,437,20684.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 162.6%.


Top Shareholders

Top 25 shareholders own 15.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
Heights Capital Management, Inc.
178,334US$925.6k0%0.14%
2.15%
The Vanguard Group, Inc.
36,541US$189.6k4.9%no data
0.87%
Geode Capital Management, LLC
14,714US$76.4k47.4%no data
0.6%
BlackRock, Inc.
10,236US$53.1k1.07%no data
0.52%
GMT Capital Corp.
8,837US$45.9k0%no data
0.24%
Citadel Advisors LLC
4,151US$21.5k415,000%no data
0.14%
Northern Trust Global Investments
2,452US$12.7k0%no data
0.14%
Two Sigma Securities, LLC, Asset Management Arm
2,377US$12.3k0%no data
0.11%
State Street Global Advisors, Inc.
1,899US$9.9k0%no data
0.098%
GSA Capital Partners LLP
1,673US$8.7k0%no data
0.083%
CARRET Asset Management, LLC
1,417US$7.4k88.9%no data
0.069%
T. Rowe Price Group, Inc.
1,172US$6.1k0%no data
0.068%
Archford Capital Strategies, LLC
1,159US$6.0k0%no data
0.054%
Robert Holmlin
924US$4.8k110%no data
0.048%
Susquehanna International Group, LLP, Asset Management Arm
819US$4.3k1.61%no data
0.037%
Inspire Advisors, LLC
621US$3.2k-6.05%no data
0.029%
Mark Oldakowski
498US$2.6k55.1%no data
0.026%
Golden State Equity Advisors, LLC
441US$2.3k0%no data
0.025%
Morgan Stanley, Investment Banking and Brokerage Investments
428US$2.2k-17.7%no data
0.023%
Two Sigma Investments, LP
394US$2.0k0%no data
0.019%
Raymond James Financial Services Advisors, Inc.
326US$1.7k5.84%no data
0.018%
Jonathan Dixon
300US$1.6k0%no data
0.017%
Christopher Stewart
294US$1.5k0%no data
0.017%
Tower Research Capital Europe Limited
284US$1.5k-33.8%no data
0.016%
Mark Adamchak
275US$1.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 18:51
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bionano Genomics, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
Jeffrey CohenLadenburg Thalmann & Company
Jason McCarthyMaxim Group